팔로우
Sara Tomei
Sara Tomei
Manager Omics Core and Biorepository - Sidra Medicine
sidra.org의 이메일 확인됨
제목
인용
인용
연도
Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment
P Li, JX Shan, XH Chen, D Zhang, LP Su, XY Huang, BQ Yu, QM Zhi, ...
Cell research 25 (5), 588-603, 2015
1382015
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
D Bedognetti, TL Spivey, Y Zhao, L Uccellini, S Tomei, ME Dudley, ...
British journal of cancer 109 (9), 2412-2423, 2013
1292013
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ...
Oncoimmunology 6 (2), e1253654, 2017
1162017
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
ML Ascierto, MO Idowu, Y Zhao, H Khalak, KK Payne, XY Wang, ...
Journal of translational medicine 11 (1), 1-11, 2013
852013
IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
D Murtas, D Maric, V De Giorgi, J Reinboth, A Worschech, P Fetsch, ...
British journal of cancer 109 (1), 76-82, 2013
542013
Detection of the BRAF V600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve …
I Marchetti, G Iervasi, CM Mazzanti, F Lessi, S Tomei, AG Naccarato, ...
Thyroid 22 (3), 292-298, 2012
542012
The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management
F Panebianco, C Mazzanti, S Tomei, P Aretini, S Franceschi, F Lessi, ...
Bmc Cancer 15 (1), 1-11, 2015
452015
Melanoma NOS1 expression promotes dysfunctional IFN signaling
Q Liu, S Tomei, ML Ascierto, V De Giorgi, D Bedognetti, C Dai, L Uccellini, ...
The Journal of clinical investigation 124 (5), 2147-2159, 2014
412014
VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma
F Lessi, CM Mazzanti, S Tomei, C Di Cristofano, A Minervini, M Menicagli, ...
Medical Oncology 31 (3), 1-7, 2014
392014
IRF5 gene polymorphisms in melanoma
L Uccellini, V De Giorgi, Y Zhao, B Tumaini, N Erdenebileg, ME Dudley, ...
Journal of translational medicine 10 (1), 1-8, 2012
382012
The immune-related role of BRAF in melanoma
S Tomei, D Bedognetti, V De Giorgi, M Sommariva, S Civini, J Reinboth, ...
Molecular oncology 9 (1), 93-104, 2015
332015
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools-a compass in the land of biomarker discovery
D Bedognetti, JM Balwit, E Wang, ML Disis, CM Britten, LG Delogu, ...
Journal of translational medicine 9 (1), 1-21, 2011
322011
The stable traits of melanoma genetics: an alternate approach to target discovery
TL Spivey, V De Giorgi, Y Zhao, D Bedognetti, Z Pos, Q Liu, S Tomei, ...
BMC genomics 13 (1), 1-11, 2012
312012
Future perspectives in melanoma research: meeting report from the" Melanoma Bridge", Napoli, December 5th-8th 2013
PA Ascierto, AM Grimaldi, AC Anderson, C Bifulco, A Cochran, C Garbe, ...
Journal of translational medicine 12 (1), 1-29, 2014
30*2014
Obesity susceptibility loci in Qataris, a highly consanguineous Arabian population
S Tomei, R Mamtani, R Al Ali, N Elkum, M Abdulmalik, A Ismail, ...
Journal of Translational Medicine 13 (1), 1-8, 2015
252015
A molecular computational model improves the preoperative diagnosis of thyroid nodules
S Tomei, I Marchetti, K Zavaglia, F Lessi, A Apollo, P Aretini, G Di Coscio, ...
BMC cancer 12 (1), 1-10, 2012
242012
Temple-baraitser syndrome and zimmermann-laband syndrome: one clinical entity?
A Mégarbané, R Al-Ali, N Choucair, M Lek, E Wang, M Ladjimi, CM Rose, ...
BMC Medical Genetics 17 (1), 1-11, 2016
232016
c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules
S Tomei, C Mazzanti, I Marchetti, L Rossi, K Zavaglia, F Lessi, A Apollo, ...
Journal of translational medicine 10 (1), 1-9, 2012
222012
Cutaneous melanoma classification: the importance of high-throughput genomic technologies
C Scatena, D Murtas, S Tomei
Frontiers in oncology, 1313, 2021
202021
Common pathways to tumor rejection
E Wang, D Bedognetti, S Tomei, FM Marincola
Annals of the New York Academy of Sciences 1284 (1), 75-79, 2013
202013
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20